Actigraphy-derived multidimensional sleep health among breast cancer survivors and controls: Pink SWAN
Journal of Cancer Survivorship · 2024
DOI: 10.1007/s11764-024-01715-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Survivorship, 2024. Verfasst von Sarah N Price und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Social Sciences and Health Policy, Wake Forest University School of Medicine, 525 Vine Street, Ste. 410, Winston-Salem, NC, 27101, USA.…. Hauptthemen laut MEDLINE: Sleep Quality, Breast Neoplasms, Cancer Survivors, Sleep Wake Disorders. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cancer Institute, United States, NIA NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Purpose
To compare breast cancer survivors (BCS) to women without breast cancer (controls) on sleep health risk factors and actigraphy-derived dimensions of sleep (duration, maintenance, timing, and regularity) and examine whether the effect of breast cancer on sleep differs by time since diagnosis.
Methods
Analyses included data from 68 BCS and 1042 controls who participated in actigraphy and Pink SWAN sub-studies within the Study of Women’s Health Across the Nation. BCS and control characteristics were compared using chi-square, Fisher’s exact, and Wilcoxon rank sum tests. Sleep measures were regressed onto breast cancer status using binomial logistic and linear regression. The interaction between BCS status and years since diagnosis (< 5; ≥ 5) was tested in these models before and after covariate adjustment.
Results
There were no overall sleep differences between BCS and controls; both groups experienced poor sleep health on average across multiple dimensions. Physical inactivity, sleep apnea, and vasomotor and depressive symptoms were associated with worse sleep in both groups. Total sleep time was lower among BCS than controls within 5 years of diagnosis (6.13 vs. 6.57 h; p = .03) but did not differ at > 5 years post-diagnosis (6.59 vs. 6.45 h; p = .32). BCS reported greater use of exogenous hormones ( p < .0001) and were twice as likely to have initiated anxiolytic use post-diagnosis ( p = .03).
Conclusions
BCS within 5 years of diagnosis experienced shorter sleep duration than controls but did not differ on other sleep parameters. Both groups experienced poor sleep health. Implications for Cancer Survivors BCS and similarly-aged women experience poor sleep health requiring assessment and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Social Sciences and Health Policy, Wake Forest University School of Medicine, 525 Vine Street, Ste. 410, Winston-Salem, NC, 27101, USA. sarahpr@wakehealth.edu.
- Tan Chingfen Graduate School of Nursing, UMass Chan Medical School, Worcester, MA, USA.
- Department of Psychiatry, University of Michigan School of Medicine, Ann Arbor, MI, USA.
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
- Department of Social Sciences and Health Policy, Wake Forest University School of Medicine, 525 Vine Street, Ste. 410, Winston-Salem, NC, 27101, USA.
Förderung
- National Cancer Institute, United States
- NIA NIH HHS
- NCI NIH HHS
- NIH HHS
- NINR NIH HHS
- National Institutes of Health
- Wake Forest University
Zitieren
APA
Price, S. N., Crawford, S. L., Swanson, L. M., Hood, M. M., & Avis, N. E. (2024). Actigraphy-derived multidimensional sleep health among breast cancer survivors and controls: Pink SWAN. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-024-01715-y
Vancouver
Price SN, Crawford SL, Swanson LM, Hood MM, Avis NE. Actigraphy-derived multidimensional sleep health among breast cancer survivors and controls: Pink SWAN. Journal of Cancer Survivorship. 2024. doi:10.1007/s11764-024-01715-y
BibTeX
@article{Price2024,
author = {Price, Sarah N and Crawford, Sybil L and Swanson, Leslie M and Hood, Michelle M and Avis, Nancy E},
title = {Actigraphy-derived multidimensional sleep health among breast cancer survivors and controls: Pink SWAN},
journal = {Journal of Cancer Survivorship},
year = {2024},
doi = {10.1007/s11764-024-01715-y}
}
EUVIMED